BioPortfolio Logo 

BioPortfolio Bulletin

www.bioportfolio.com 

  http://www.bioportfolio.co.uk/bulletin_47.htm                          July 13 2004

Lead Sponsor:
  		  Biotech industry expert Dr. Ron Garren analyzes newsworthy events in the medical marketplace and places them in the context of value to the investor. Through his website, he distributes frequent email alerts to subscribers. An archive of past alerts, along with a model portfolio of biotech stocks is also available.

http://www.biotechinsight.com/
In this Week's issue:
1) Biotech industry expert Dr. Ron Garren analyzes newsworthy events - see above
 2) Bioterrorism, Anthrax and Smallpox Information Resources
3) Pharmaceutical Pricing Strategies:  Optimizing returns throughout R&D and marketing 3 for 2 offer
4) New Reports: 
  • Analytical Tool Competitive Outlook on HCV
  • Analytical Tool: Frontlines in Cancer Therapeutics I
  • Model Animal Systems Emerging Applications and Commercial Opportunities in Drug Discovery and Development
  • Evaluating Online Advertising Opportunities Life Science Portals

4) Emerging Drug Discovery - Scientific Publication Alerts
5) BioWatch News Email Alerts
Bioterrorism, Anthrax and Smallpox Information Resources
View reports:   BioPortfolio have created a unique web index - please evaluate:

 

Pharmaceutical Pricing Strategies:  Optimizing returns throughout R&D and marketing
The Cardiovascular Market Outlook to 2008  

Special Offer: Save up to $1199.00

The latest pricing report from Reuters Business Insight ‘Pharmaceutical Pricing Strategies: Optimizing returns throughout R&D and marketing’ investigates the global pricing of pharmaceutical and biotechnology products allowing you to strengthen your competitive strategy and map out the future scenarios which could affect your company. This report provides a framework for devising an optimal pricing strategy to enable you to maximize the returns from new and established products. See detail at:
http://www.bioportfolio.com/cgi-bin/acatalog/Reuters_2003.html#a167

Discover whether your predictions of trends in pharmaceutical pricing are consistent with key industry analysts’ and determine how your company will deal with the impact of these trends, with the help of this management report.

Special Offer: Save up to $1199.00

Order your copy of ‘Pharmaceutical Pricing Strategies’ before Friday 23rd July 2004, and receive ’Pharmaceutical Portfolio Management’ and ‘The Pharmaceutical Parallel Trade Outlook’ for half price.

Email peter.barfoot@bioportfolio.com today

Reuters Business Insight reports are published by Datamonitor, in association with Reuters. Reuters, the sphere logo and Reuters Business Insight are trade marks of the Reuters group of companies around the world and are used by Datamonitor under licence from Reuters

New Reports:

Analytical Tool Competitive Outlook on HCV

  

Analytical Tool Competitive Outlook on HCV

BioSeeker Group's "Analytical Tool: Competitive Outlook on HCV", represents a powerful product combination of the independent and unbiased analytical report Competitive Outlook on HCV: What to Know & Expect in R&D and Business Development and the HCV R&D and Business Development Database, which gives you access to substantial background information on the subject covered by the report, i.e. company profiles, R&D projects, and business collaborations. To order click:
http://www.bioportfolio.com/cgi-bin/acatalog/BioSeeker.html#a679

 

Analytical Tool Competitive Outlook on HCV

  

Analytical Tool: Frontlines in Cancer Therapeutics I

In this very extensive Analytical Tool, BioSeeker has selected a number of fields and topics in cancer therapy R&D, which have all seen tremendous advancements lately. Monoclonal antibodies, anti-angiogenesis / vascular targeting, protein kinase inhibitors, integrin antagonists, VEGF-Trap and Endostatin are covered in a number of reports and databases, included in this Analytical Tool. This range of therapeutic strategies and targets include many strong interrelationships in terms of technology, R&D and competition. An example of this is Avastin, a monoclonal antibody targeting the VEGF signaling pathway, partly resulting in an antiangiogenetic effect.

With the products included in this Analytical Tool, you will be guided through some of the most active, competitive and interesting fields in oncology today. While providing a complete overview of these topics, this package will also allow you the opportunity to carry out independent in-depth analysis on these fields, thanks to the immense and complete data sets included. This Analytical Tool also forecasts the developmental progress in terms of indications, type of drugs, drug effects, targets, and mechanism of actions. Hundreds of companies and their activities are described and evaluated. More than 1000 cancer projects are included.  To order click:
 http://www.bioportfolio.com/cgi-bin/acatalog/BioSeeker.html#a676   

 

    Model Animal Systems Emerging Applications and Commercial Opportunities in Drug Discovery and Development
Allan B. Haberman, Ph.D., Haberman Associates, The Biopharmaceutical Consortium

Contributing Editors: Malorye A. Branca and Laurie L. Sullivan, Cambridge Healthtech Advisors

Model Animal Systems: Emerging Applications and Commercial Opportunities in Drug Discovery and Development reviews the progress in the application of animal models to drug discovery and development, and discusses the leading companies providing tools in this field, the areas of greatest unmet need, and the most important emerging applications. Models discussed include yeast, the nematode (Caenorhabditis elegans), the fruitfly (Drosophila melanogaster), the zebrafish (Danio rerio), the mouse, and the rat.

http://www.bioportfolio.com/cgi-bin/acatalog/Cambridge_Healthtech_Advisors.html 

 

Evaluating Online Advertising Opportunities Life Science Portals   Evaluating Online Advertising Opportunities Life Science Portals
Commercial life science portals provide users with "one-stop" access to the information they need and offer a wide array of content that could be of interest to life science researchers, such as scientific articles, news briefs, product and supplier information, and professional resources. These focused, online communities have emerged not only to encourage repeat visits from scientists, but also to attract advertising dollars and sponsorships. Online advertising at such web sites can take a variety of forms—from simple banner ads to paid content to electronic storefronts. However, given the bewildering array of life science portals, the question of where to place these ads has become extremely complex. Based on a 36-question survey of more than 1,300 life scientists, Evaluating Online Advertising Opportunities @ Life Science Portals is designed to help marketers understand scientists’ perspectives on web content, banner ads and e-newsletters. By doing so, this report will help life science executives decide where to spend their advertising budget using the same criteria as their scientific customers, rather than assessing the value of a portal on the basis of "hits", "pages served" and "unique user" statistics.

http://www.bioportfolio.com/cgi-bin/acatalog/copy_of_bioinformatics_1.html#a641 

 

Emerging Drug Discovery - Scientific Publication Alerts


SUBSCRIBE HERE 

$95.00 per channel per year

 

DailyUpdates was launched in 2002 by the pharmaceutical analysts LeadDiscovery and represents the first "newsfeed" that identifies breaking scientific publications with drug development potential. 

Using proprietary data retrieval strategies LeadDiscovery selects daily 1,000 PubMed articles and press releases.  The selected articles and releases are then scanned by an industrial research panel which judges those articles considered to be of greatest benefit for the drug development sector. 

Selected publications as well as press releases are then listed on DailyUpdates six therapeutic channels that match core R&D areas;

BioWatch News Email Alerts

News EMAIL alerts - click here!

 

 

We have used the BioPortfolio BioWatch News email alert service for two years to track commercial developments in diabetes, oncology and CNS – we will be subscribing for a third year because we find it a user friendly and an excellent vehicle for keeping us aware”.  Lester Salans.

Download the BioWatch News Email Alert pdf brochure (100 Kb) and order form!

Subscribe to BioWatch News alerts - Step 1 of 4
Step 1 - select the type of subscription:

  • Silver membership: Allows you to choose up to 10 pre-defined alert topics - each alert topic costs $25.00 per year. Click here!

  • Gold membership: You define the alert topics based on keywords of importance to you - each personal alert topic costs $50.00 per year.  During the subscription period you can change the search words used for each topic. To subscribe go directly to Step 4 now!

  • Corporate membership: Corporate subscribers identify the keywords/topics of importance and BioPortfolio emails the news alerts for each topic to a separate email address. The corporate internal email system then forwards the email alerts to employees who have subscribed to the respective topic. $200.00 per topic per year for small/medium biotech organizations and $400.00 per topic per year for large pharmaceutical organizations.  To subscribe email peter.barfoot@bioportfolio.com.

http://www.bioportfolio.com/news_tracking/index.htm 

 

Contact us:
Editorial and features: peter.barfoot@bioportfolio.com 

Subscriber information:
To subscribe for the BioPortfolio Bulletin in HTML, email:
bioportfolio-subscribe-request@peach.ease.lsoft.com

To unsubscribe, email: bioportfolio-signoff-request@peach.ease.lsoft.com WITH NO SUBJECT.  The system will automatically remove your email address from the list based on your email address.  If your email has changed please email peter.barfoot@bioportfolio.com with a list of your email address and we will manually unsubscribe for you.  Thank you for your understanding.

©2004 BioPortfolio Limited - http://www.bioportfolio.com and http://www.bioportfolio.co.uk